Home » Newsletters » BioWorld Science

BioWorld Science

June 3, 1998

View Archived Issues

Idec receives patent protection for radioimmunotherapy

GlycoDesign seeking licensees for its carbohydrate-processing inhibitor GD0039

NeXstar granted option to license vaccine technology

Biomira sells blood test kits to Centocor

Company Profile: Small Molecule Therapeutics

OSI Pharmaceuticals licenses gene transcription technology to Aurora Biosciences

Matritech's bladder cancer test approved in Japan

Inex gene therapy reduces metastatic tumors in preclinical trials

Gem Pharmaceuticals seeks development partners for anticancer agent

Compounds reduce Abeta protein by at least 70% in AD preclinical model

Patient enrollment complete for RII retinamide phase I/II trial

Celsion to evaluate BPH system in phase I trial

New Lilly compounds for postmenopausal syndrome

Inhibitors of cysteine protease from SKB for bone and cartilage disorders

Antimicrotubule cryptophycins developed by Lilly, U.S. university researchers

Procter & Gamble prepares inhibitors of mammalian metalloproteases

Compounds for schizophrenia without EPS developed at AHP

Nikken Chemicals presents new antiasthmatic agents

Novartis files for U.S. marketing approval of Sandostatin LAR

Chinese herbal drug tetramethylpyrazine inhibits ET-1-induced vasoconstriction

Prandin introduced for treatment of type II diabetes in U.S.

ECE inhibitor prevents cerebral vasospasm in rabbits

European Commission clears rituximab for marketing in member countries

Vasomax phase III results presented at AUA meeting

Transurethral alprostadil: conflicting results presented at AUA meeting

FDA advisory committee recommends approval of Ontak for CTCL

IL-12 enhances the activity of antibiotics against M. avium infection

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...